Use of cabozantinib in a patient with EGFR-mutated non–small-cell lung cancer harboring acquired CCDC6-RET fusion

Young Kwang Chae*, Pedro Viveiros, Caio T. Heleno, Haris Bilal, Bhoomika A. Sukhadia, Michael S. Oh, Muhamad Mubbashir Sheikh, Wade T. Iams, Lee Chun Park

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
JournalJCO Precision Oncology
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this